BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 22, 2026
Home » Authors » Diana Tucker

Articles by Diana Tucker

New imaging modalities focus on breast cancer

Dec. 7, 2010
By Diana Tucker

How to treat high platelet reactivity: still confusing

Nov. 22, 2010
By Diana Tucker

PFO/stroke connection remains perplexing medical conundrum

Nov. 17, 2010
By Diana Tucker
CHICAGO — Sometimes logic and anecdotal information just can't connect the dots. Such was the case with the long-awaited CLOSURE 1 randomized controlled clinical trial results to evaluate the safety and efficacy of NMT Medical's (Boston) STARFlex septal closure system that were reported this week at the American Heart Association (AHA; Dallas) 2010 Scientific Sessions. (Medical Device Daily)
Read More

Can advanced surgical technologies survive in today's economy?

Nov. 1, 2010
By Diana Tucker

Newest research shows some surgeries no longer necessary

Oct. 8, 2010
By Diana Tucker

AAD meeting shows laser procedures are a girl's new best friend

Oct. 1, 2010
By Diana Tucker

No algorithm for selecting appropriate bariatric procedure for specific patient

Aug. 1, 2010
By Diana Tucker

NOTES goes from experimental to investigational with trial

July 23, 2010
By Diana Tucker
CHICAGO – The initial excitement and big buzz about Natural Orifice Translumenal Endoscopic Surgery®(NOTES) has been replaced with the heavy lifting of entering hard, long clinical trials that carefully evaluate the potential benefits and risks associated with the novel technique. The 5th meeting of the Natural Orifice Surgery Consortium for Assessment and Research® (NOSCAR) was held here with exciting news of initial human trials being performed. (Medical Device Daily)
Read More

Advanced laparascopic surgery: A blended mix of new technologies

May 1, 2010
By Diana Tucker

Surgeon scientists becoming advocates of cancer patients

March 30, 2010
By Diana Tucker
Chicago — With a backdrop of the newly passed Healthcare Reform Bill, cancer surgeons whose practices may be altered forever, met here for the advancement of pure science and humanitarianism. The objective of the American College of Surgeons Oncology Group (ACOSOG; Durham, North Carolina) is to study cancer patient outcomes using clinical trials as a measure for new advanced methods in order to further advance patient care. (Medical Device Daily)
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 21, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing